T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
Jeffrey M. Critchfield(National Institutes of Health), Michael K. Racke(National Institute of Neurological Disorders and Stroke), Juan Carlos Zúñiga‐Pflücker(National Institutes of Health), Barbara Cannella(Albert Einstein College of Medicine), Cedric S. Raine(Albert Einstein College of Medicine), Joan Goverman(University of Washington), Michael J. Lenardo(National Institutes of Health)
Cited by 524
Abstract
Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.
Related Papers
No related papers found
Powered by citation graph analysis